MolNFT v1 · #109091 · protein
Crystal structure of mycobacterium tuberculosis uracil-DNA glycosylase in complex with 6-aminouracil, form IV
4WS3: “Crystal structure of mycobacterium tuberculosis uracil-DNA glycosylase in complex with 6-aminouracil, form IV”. X-ray diffraction, 2 ligands (6UA, CL), 2 pockets (best druggability 0.51). MolNFT v1 #109091 on GenesisL1: 3D…
- PDB
- 4WS3
- Type
- protein
- Length
- 224 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Uracil-DNA glycosylase
- EC
- 3.2.2.27
- UniProt
- P9WFQ9
- Ligands
- 6UA, CL
- Pockets
- 2 · best druggability 0.51
Structure
x-ray diffraction · 1 distinct chain · 43% helix, 10% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Uracil-DNA glycosylase (EC 3.2.2.27) | protein | 224 | 43% helix, 10% strand | P9WFQ9 |
Ligands and binding sites
- 6UA · 6-aminopyrimidine-2,4(3H,5H)-dione · ligand · chains A
- CL · Chloride ion · ion · chains A
- DMS · Dimethyl sulfoxide · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 141 | 0.51 | 0.79 | 35 | 6UA, CL |
| 2 | 74 | 0.33 | 0.75 | 21 | empty |
Compared structures
- P9WFQ9 · AlphaFold monomer V2.0 prediction for uracil-DNA glycosylase (P9WFQ9) · a predicted model of the same protein · chain A against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P9WFQ9
- Elsewhere: RCSB PDB 4WS3 · PDBe 4WS3 · UniProt P9WFQ9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.